NationalunP2
The Centre for Health Intervention and Policy Evaluation Research at NUS is seeking a researcher to lead Phase III of the RODEO project, focusing on comparative analyses using oncology real-world data. The role involves designing and conducting comparative effectiveness studies across multiple myeloma, non-small cell lung cancer, and ovarian cancer using structured and processed unstructured data from electronic medical records. This position is ideal for candidates with training in biostatistics, epidemiology, or related fields who have experience working with observational healthcare datasets.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for NationalunP2.
NationalunP2 didn’t post a salary, so this is our estimate from similar listings.
Right around the average for this role
Associate Director, Global Epidemiology and Real-World Evidence
GSK plc
Real-World Data Science Manager
Novo Nordisk A/S
Biostatistician I
State of Utah
Real World Data Statistician I/II
AstraZeneca
Associate Director I/II, Real World Data Statistics
AstraZeneca
Senior Scientist, Clinical Intelligence Evidence
AstraZeneca